A pill used for breast cancer has been shown to help treat certain early-stage, hard-to-treat cases. It was studied in patients with BRCA1 and BRCA2 mutations.
When it comes to cancer it does not discriminate. Battling the disease is bad enough, but there's also a financial burden hanging over survivors.
The U.S. Food and Drug Administration convenes Tuesday for the first meeting in a decade to consider clawing back approvals from several cancer drugs that have failed to show they extend or improve life.
The scientist who won the race to deliver the first widely used COVID-19 vaccine says the technology behind it will soon be used to fight cancer.